Amplyx Pharmaceuticals, Inc.
Pharmaceutical company · San Diego, California, United States
Amplyx Pharmaceuticals, Inc. is a pharmaceutical company headquartered in San Diego, California, United States. It has received 13 US government small-business research awards (SBIR/STTR) from health agencies, $11 million in total, most recently in 2017. It has reported private securities offerings to the US SEC, most recently $91 million sold in a notice filed in 2020.
Amplyx Pharmaceuticals at a glance
What does Amplyx Pharmaceuticals do?
US government research funding
13 SBIR/STTR small-business research awards from US health agencies, $11.4 million in total (2011 to 2017). NIH funding came from the National Institute of Allergy and Infectious Diseases.
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $91.3 million sold (2020).
Frequently asked questions about Amplyx Pharmaceuticals
Where is Amplyx Pharmaceuticals headquartered?
Amplyx Pharmaceuticals, Inc. is headquartered in San Diego, California, United States.
What does Amplyx Pharmaceuticals do?
Amplyx Pharmaceuticals, Inc. is a pharmaceutical company.
Similar companies
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Oncternal Therapeutics, Inc.San Diego, California, United States
- Acadia Pharmaceuticals IncSan Diego, California, United States
- ViaCyte Inc.San Diego, California, United States
- Avidity Biosciences, Inc.San Diego, California, United States
- Ligand Pharmaceuticals IncSan Diego, California, United States
- Arena Pharmaceuticals IncSan Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences